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Abstract 
Cluster of differentiation (CD81) is a type of protein, 
which is encoded by CD81 gene. Beside that CD81 
is also known under other names such as Target of 
the Antiproliferative Antibody 1 (TAPA-1) and 
Tetraspanin-28 (TSPAN28). Location of CD81 is 
known to be on chromosome 11 (11p15.5), where it 
contains 15-20 bases in length. It is expressed mostly 
in cells of testis, ovary, endometrium, placenta, bone 
marrow, smooth muscles and others.  
The main function of the CD81 protein is to mediate 
signal transduction events, which are important for 
cells' development, activation, growth and motility. 
The CD81 gene is also known as a candidate for 
many malignancies because of its location. The 
characteristic feature of CD81 is that it is highly 
hydrophobic and contains a short N- and C-terminal 
cytoplasmic domains together with cytoplasmic 
cysteines, potential sites of palmitoylation as well as 
four transmembrane domains where they together 
hold the protein in a cell membrane. There are two 
CD81 isoforms, isoform 1 and isoform 2. Isoforms 
of CD81 are usually found in a tumor-suppressor 
region where they have a great impact on tumor 
development. There has always been a high interest 
in research on CD81 function in viral disease 
development.  
In fact, it is known that CD81 contributes in the 
development of diseases such as hepatitis C, malaria 
and various types of cancer.  
Since the complete effect of CD81 is unknown, 
further research and scientific methodology could 
potentially discover all possible functions and 
mechanisms regulated by the CD81 protein in 
human body. 
Keywords 
CD81, TAPA-1, Tetraspanin-28, malignancies, 
isoforms, viral disease. 
Identity 
Other names 
TAPA-1; TAPA1; TAPA; CD 81 antigen; CD81 
molecule; TSPAN28; TSPAN-28; S5.7; CVID6 
HGNC (Hugo): CD81 
Location: 11p15.5 
DNA/RNA 
The highest level of CD81 gene expression is in 
endometrium (RPKM 241.8), fat (RPKM 237.1), 
lung (RPKM 191.2) and 24 other tissues in the 
human body.  
Proteins encoded by the CD81 gene are important for 
transduction of signals, cell development, growth 
and motility (RefSeq NCBI et al., 2019). 
Figure 1. Mapping of CD81 gene on chromosome 11p15.5 (from Ensembl CD81 gene). 
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Cluster of Differentiation 81 (CD81) is a type of 
protein, which belongs to tetraspanin family of 
proteins (Thomas and Mohler, 2011). According to 
the study, it is an important molecule for the 
biological system of living organisms that regulates 
several types of mechanisms in the body (Thomas 
and Mohler, 2011). The molecule was previously 
known as TAPA-1 but changed its name to CD81, 
after the Fifth International Workshop on Human 
Leukocyte Differentiation Antigens' (IUIS/WHO 
Subcommittee on CD Nomenclature, 1994).  
CD81 gene constitutes a protein coding gene which 
is located in the chromosomal region 11p15.5 of 
human genome. Using 5A6 (immunoglobulin- γ1), a 
monoclonal antiproliferative antibody, Oren et al. 
(1990) performed the first isolation of cDNAs 
encoding CD81. The chromosomal localization of 
CD81 gene in the short arm of chromosome 11 was 
determined by Andria et al. (1991) in Southern blot 
experiments in which DNA isolated from somatic 
cell hybrids was used. In order to assign CD81 gene 
to a specific region on the chromosome 11, 
Virtaneva et al. (1994) performed experiments by 
hybridizing CD81 gene to derivative somatic cell 
hybrid DNAs of human chromosome 11. The exact 
location of CD81 gene is shown in the figure 1. To 
date, 17 transcript variants have been found for this 
gene.  
As indicated by Andria et al. (1991), the 5' 
untranslated region of the CD81 gene is abundant in 
CpG islands, which is a common feature observed in 
many housekeeping genes (Andria et al.,1991; Levy 
et al., 1998). High content of G + C nucleotides in 
this region correlates with a high susceptibility to 
methylation events, which can affect the expression 
of the receptor (Houldsworth et al., 2013). It also 
contains a TATA box at -25 position and 
presumably, binding sites for SP1 transcription 
factor (Maecker et al., 1997). Additionally, it has 
been reported that the region in which CD81 gene is 
located constitutes a tumor-suppressor region, which 
makes a CD81 gene an important candidate for 
various malignancies. 
Transcription 
There are several ongoing studies regarding the 
CD81 gene due to its transcriptional activity (Hong 
et al., 2014; Tardif et al., 2005). In an experiment in 
which promoter analysis was performed, it has been 
shown that there is an essential role of the SP1 
transcription factor in CD81-induced MT1-MMP 
transcription (Hong et al., 2014). Having CD81 with 
high MT1-MMP expression levels is of a great 
importance since it is associated with malignant 
melanoma development (Hong et al., 2014). The 
antigen itself is very much vital for the malignancies, 
primarily due to the location of the CD81 gene in a 
tumour-suppressor region (Levy et al., 2014). 
Mature transcript of CD81 is made of eight exons, 
all of which code information for protein synthesis. 
The transcript itself is 1,714 bp long. 
Protein 
Description 
CD81 antigen, previously known as TAPA1, 
constitues a membrane protein of 26-kDa molecular 
weight, which is expressed in many cell types, 
including hemopoietic, endothelial as well as 
epithelial cells. It is a founding member of a highly 
conserved tetraspan family of transmembrane 4 
superfamily, also known as tetraspanin family. 
Members of this family are expressed not only in 
mammals, but also in all other multicellular 
organisms, including insects such as Drosophila, 
plants as well as fungi. CD81 is a highly 
hydrophobic protein which contains a short N- and 
C-terminal cytoplasmic domains with cytoplasmic 






Atlas Genet Cytogenet Oncol Haematol. 2020; 24(7) 267 
 
cysteins, potential sites of palmitoylation as well as 
four transmembrane domains (TM 1-4) that hold the 
protein in a cell membrane. The protein folds itself 
creating a large extracellular loop (LEL) with CCG 
motif and two disulfide bridges, small extracellular 
loop (SEL) and even a smaller loop of intracellular 
location (Levy, 2014). Unlike many other members 
of the family, CD81 does not undergo glycosylation. 
The protein exibits a strong homology with two 
antigens - CD37 (65% identical) as well as ME491 
melanoma-associated antigen (98% identical) also 
known as CD63 molecule. Originally, CD81 protein 
was characterized as a target of an antiproliferative 
antibody that leads to the inhibition of B cell 
proliferation (Levy, 2014).  
 
Figure 3. CD81 structure (Levy, 2014). 
 
C According to the Zimmerman et al. (2016), 
transmembrane parts of CD81 contain two largely 
disconnected couples of spirals, covered with a 
bulky extracellular loop at the exterior membrane 
leaflet. These two sets of coils converge at the 
position of internal leaflet to generate an 
intramembrane abridged with supplementary  
electron concentration corresponding to a 
cholesterol molecule in a cavity. Molecular 
subtleties simulation recognizes a supplementary 
conformation in which extracellular loop splits 
considerably from the transmembrane domain. 
Cholesterol binding appears to modulate CD81 
activity in cells, signifying a probable mechanism for 
regulation of tetraspanin occupation. 
 
Figure 4. Model of CD81 protein (Source: SWISS-MODEL 
https://swissmodel.expasy.org/interactive) 
Expression 
On a protein level the expression of CD81 occurs on 
B-cells, hepatocytes, monocytes/macrophages and 
on both naive and memory CD4-positive T cells 
(Takeda et al., 2003; Silvie et al., 2003; van Zelm et 
al., 2010; Sagi et al., 2012) 
 
Figure 5. Structure of CD81 protein (Source: UNIPORT 
https://www.uniprot.org/uniprot/P60033) 
Localisation 
CD81 gene can be localised in the tumor-suppressor 
region where two different isoforms can be found. 
 
Figure 6. CD81 isoform 1. Location 10-228 (RefSeq NCBI et al., 2019) 
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Figure 7. CD81 isoform 2. Location 42-131 (RefSeq NCBI et al., 2019). 
 
Figure 8. CD81-cholesterol interactions (Zimmerman et al., 
2016). 
Function 
CD 81 plays a significant role in several 
physiological functions such as regulation of cell 
activation, development, motility and growth 
(Fagerberg et al., 2014). It is also involved in signal 
transduction. CD81 encoded glycoprotein associated 
with the cell surface is known to create a complex 
with integrins, which helps to promote fusion of 
muscle cells as well as maintenance of myotubes.  
 
According to Thomas and Mohler (2011), CD81 is 
expressed on the surface of oocytes and absence of 
this molecule is associated with a reduced fertility in 
the mice system due to egg-sperm fusion defects. On 
the other hand, Kaji et al. (2002) proved that CD81 
and CD9 have corresponding utilities in the egg-
sperm fusion. The activity of CD9 is reduced by the 
absence of the CD81 which was observed in the mice 
model system. There are several reports available in 
which it has been proven that CD81 actively 
prevents development of some viral diseases like 
hepatitis C virus (Nalesnik and Kanto, 2010). Geisert 
et al. (2002) showed that CD81 is involved in the 
development of the central nervous system. 
According to the experiment, in comparison to 
normal mice, CD81 mutation in the cells of central 
nervous system results in the development of 30% 
larger brains.  
 
When CD81 is increased in the body, it may be 
promoting breast cancer. Scientific study designed 
by Zhang et al. (2018) on MDA-MB-435S and 
MDA-MB-231 human breast cancer cell lines 
showed that when CD81 expression increases as an 
effect it can promote breast cancer. Malaria parasite 
Plasmodium uses CD81 membrane protein to attack 
liver cells in a human body (Bruening et al., 2018). 
It is also known that CD81 has an ability to bind to 
cholesterol where the amount of cholesterol controls 
the expression of CD81 (van Zelm et al., 
2010; Vences-Catalán et al., 2015). 
Homology 
Highest homology level of CD81 protein can be 
found between humans and mice (Boismenu et al., 
1996). By analysing the homology between human 
and mouse variants, it has been shown that the 
transmembrane domain residues are mostly 
sequentially conserved. Beside that it has been also 
proven that extracellular domains significantly differ 
from each other as presented in a figure 9 (Frolikova 
et al., 2018). The protein exhibits a strong homology 
with two antigens - CD37 (65% identical) as well as 
ME491, melanoma-associated antigen (98% 
identical) also known as CD63 molecule (Levy et al., 
2014). 
Figure 9. CD81 in human and mouse (Frolikova et al., 
2018). Figure 9 presents the transmembrane domain 
residues and differences between extracellular domains. 
The whole protein consists of non-identical acids between 
human and mouse CD81 and CD9 projected onto the 
model of CD9/CD81 complex. The difference is the amount 
of amino acids where CD81 contains 17 different amino 
acids in the extracellular domain while CD9 differs in 25 
amino acids on same location (Frolikova et al.,2018). 
Mutations 
Mutations associated with CD81 are often caused by 
viral infections such as hepatitis C. According to the 
study where the hepatitis C virus envelope protein 
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(E)2 interacts with cellular receptor CD81 it was 
possible to obtain the modulation of B and T cell 
function. Despite positive results, the importance of 
the mutation is unknown even though the mutation 
was caused by the modulation of these two proteins 
as well as the effect and the correlation between 
CD81 and binding regions of HCV Geno/subtypes 
(Kronenberger B et al., 2004).  
Mutations associated with CD81 are often caused by 
viral infections such as hepatitis C. According to the 
study where the hepatitis C virus envelope protein 
(E)2 interacts with cellular receptor CD81 it was 
possible to obtain the modulation of B and T cell 
function. Despite positive It is known that CD19 and 
CD81 depend on each other regardless if the 
mutation occurs or not. Dependence was described 
on a group of patients with an increased 
susceptibility to infection, 
hypogammaglobulinemia, and normal numbers of 
mature B cells in blood, but all the patients had a 
mutation in CD19 in common (van Zelm et al., 
2006). Usually, CD81 is expressed on blood cells 
such as blood lymphocytes, monocytes, basophilic 
granulocytes, and eosinophils. The absence of CD81 
in membrane has never been found in humans 
before. However, a study performed on B cells from 
611 neonatal cord blood samples showed that the 
absence can occur (Duijts et al., 2009).  
Mutations associated with CD81 are often caused by 
viral infections such as hepatitis C. According to the 
study where the hepatitis C virus envelope  
protein (E)2 interacts with cellular receptor CD81 it 
was possible to obtain the modulation of B and T cell 
function. Despite positive In a study where a patient 
had severe nephropathy and profound 
hypogammaglobulinemia as well as 
immunodeficiency with decreased memory B cell 
numbers, with help of DNA sequencing of all 8 
exons in which homozygous G>A substitution was 
found, splice sites were directly identified 
downstream of exon 6: c.561+1G>A. This kind of 
exons cause frameshift before the fourth 
transmembrane domain as well as premature stop (p. 
Glu188MetfsX13). Because of the mutation, the 
splice donor site was disrupted and sixth intron in 
cryptic splice site was used (van Zelm et al., 2010) 
Somatic 
CD81 also has an ability to regulate CD19 in B-
lymphocytes, which can trigger the progression of 
hepatitis C virus infection in human cells. Scientific 
research in which human cells underwent a 
procedure of immunohistological staining proved 
that normal hematopoietic tissue resulted in a strong 
staining for CD81 in a normal germinal centre B cell. 
Another analytical method called high-dimensional 
flow cytometry confirmed that among B and T cell 
subsets, germinal centre B cells had the highest level 
of CD81 expression (Luo et al., 2010). Moreover, 
scientific study performed on mice showed that there 
is a correlation between the amount of CD81 and 
CD9 presented in somatic cells with successful 
fertilisation of spices..
 
Figure 10. Presentation of the CD81 gene with 8 exons. Patient who participated in the study was homozygous for a splice site 
mutation downstream of exon 6 (exon6+1 G>A). This is resulting in the usage of a cryptic splice site 13 nucleotides downstream 
of exon 6. Premature stop codon upstream of the fourth transmembrane domain of the CD81 protein, TM transmembrane 
domain; SEL, short extracellular loop; LEL, large extracellular loop as well as frameshift are caused by the insertion of the 13-
nucleotide region (van Zelm et al., 2010).
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It is proven that the lack of CD81 and CD9 leads to 
a lower chance of successful fertilisation. In somatic 
cells, CD81 and CD9 associate with each other 
together with other, non-tetraspanin molecules, 
creating proteolipid complexes. Artificial removal of 
CD81 gene in mice leads to 40% reduction of female 
fertility (Rubinstein et al., 2006). 
Epigenetics 
Cluster analysis have found 25 types of genes that 
were hypermethylated and hypomethylated, 
respectively, in 20% in all of the studies. One of the 
most frequently hypermethylated genes was CD81. 
CD81 has been found in larger amounts as target of 
polycomb repressive complex 2 in embryonic stem 
cells in a medical condition called Glioblastoma 
multiforme, a devastating brain tumor in adults. 
CD81 is a member of membranal-embedded 
tetraspanin superfamily and it is usually observed in 
multiple myelomas. Tetraspanin genes associated 
with signalling proteins modulate fundamental 
biological functions and can potentially be involved 
in CD81 gene as a metastasis suppressor (Martinez 
et al., 2009). 
Implicated in 
The CD81 protein is a highly involved in the 
development of several diseases including hepatitis 
C, malaria, several types of cancer, HIV, fungal 
diseases, parasites etc. The main mechanism 
involves CD81 acting as a signalling molecule with 
a pathogen attached to the extracellular loop of 
CD81. This means that it acts as a getaway for the 
infection. It has also been proven that CD81 is 
important for the immune system due to its close 
association with CD19 in B cells. Simultaneously, it 
plays an important role in T cells by acting as a 
costimulatory agent for CD3 (Vences-Catalán et al., 
2015). Presumably, further research on CD81 may 
provide information on all other possible functions 
and mechanisms of action of this molecule (Monk 
and Partridge, 2012). 
Hepatitis C 
Research on hepatitis C virus and CD81 has always 
been of a high interest. CD81 is considered to be a 
central regulator involved in the HCV lifecycle. It 
has been proven that due to its location in the cell 
membrane of hepatocytes, CD81 interacts with HCV 
entry factors and by that it plays a key role in the 
initiation of infection. The HCV infection begins 
when viral particles bind to glycosaminoglycans 
(GAG) as well as Low Density Lipoproteins 
Receptors (LDL-R), which are non-specific factors 
located on the cell surface. This stage is then 
followed by a direct interaction of HCV with an 
entry factors which are cell specific. Among these 
factors, CD81 constitutes the most studied and the 
best characterized entry factor involved in the HCV 
infection (Pileri et al., 1998; Cormier et al., 2004; 
Fénéant et al., 2014). Pileri et al. (1998) 
demonstrated that the virus protein E2 binds large 
extracellular loop of CD81 protein and that the 
disruption of the E2-CD81 interaction, results in 
hindering of the HCV entry and infection. 
Malaria 
Malaria parasites such as Plasmodium 
yoelii and Plasmodium falciparum sporozoites are 
involved in the CD81 expression. In a study where 
correlation of CD81 and malaria infection has been 
analysed, direct link between CD81 and cholesterol 
during the infection of malaria parasites has been 
shown. Additionally, it has been proven that the 
loops of these tetraspanins contain a new type of 
microdomains that potentially could be used by 
pathogens for infection (Silvie et al., 2006). 
Breast cancer 
The role of CD81 protein in breast cancer is 
unknown (Zhang et al., 2018). According to the 
scientific study the expression of CD81 during breast 
cancer state is significantly increased compared to 
the normal breast tissue. The increase of CD81 is 
associated with lymph node metastasis. (Zhang et al., 
2018). It has been concluded that CD81 may be used 
as a prognostic biomarker associated with poor 
patient prognosis in breast cancer (Zhang et al., 
2018). 
Hepatocellular carcinoma 
CD81 is known to be a receptor for hepatitis C. This 
kind of characteristic is a major cause of 
hepatocellular carcinoma (Charrin et al., 2001). 
Acute myeloid leukaemia (AML) 
The medical condition AML is known to be 
heterogeneous disease and lately, novel prognostic 
factors have been of a great importance in order to 
propose appropriate therapy. CD81 does have 
negative impact on survival outcome in AML 
patients. It is known that CD81 could be used in 
therapeutic approaches in stating proper AML 
treatment. Further studies are needed in order to 
confirm prognostic impact of CD81 and AML 
(Boyer et al., 2016). 
HIV infection 
Some reports have indicated that CD81 is associated 
with CD4, which provides a costimulatory signal 
that increases HIV-1 gene expression (Gordón-
Alonso et al., 2006) CD81 has the ability to deliver 
a co-signal for T cells. This action triggers cytokine 
production, which leads to the cellular proliferation. 
Signalling processes are initiated through the T-cell 
receptor (TCR)/CD3 complex where coactivator 
CD28 affects immunodeficiency virus type 1 (HIV-
1) gene expression. According to Tardig et al. (2005) 
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no study has investigated the putative costimulatory 
activity of CD81 on HIV-1 transcriptional activity. 
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